Foot Locker Plunges On “Softened” Sneaker Demand
Low- to mid-income consumers, feeling the brunt of sticky inflation, elevated prices, and high interest rates, have dialed back their demand for fancy sneakers. As a result, shoe retailer chain Foot Locker slashed its full-year guidance after reporting dismal third-quarter earnings.
Foot Locker’s third-quarter results missed the Bloomberg Consensus expectations on the top and bottom lines. The company blamed “softened” consumer trends and a high “promotional environment” across the marketplace.
Here’s a snapshot of the third quarter (courtesy of Bloomberg):
- Comparable sales +2.4%, estimate +2.76%
- Adjusted EPS 33c vs. 30c y/y, estimate 41c
- Loss per share 34c vs. EPS 30c y/y
- Sales $1.96 billion, -1.4% y/y, estimate $2.02 billion
- Total location count 2,450, -6% y/y, estimate 2,448
- Foot Locker US stores 691, -6.6% y/y, estimate 691.86
- Kids Foot Locker stores 376, -4.1% y/y, estimate 377.38
- Champs Sports stores 390, -18% y/y, estimate 384.63
- Gross margin +230 bps
“Consumer spending trends softened following the peak Back-to-School period in August, and the promotional environment was more elevated than anticipated,” CEO Mary Dillon wrote in a press release, adding, “We saw a meaningful and positive acceleration over the key Thanksgiving week period, especially in stores.”
Dillon continued: “Despite that strong performance, we are taking a more cautious view and are lowering our full-year sales and earnings outlook due to a more promotional environment and softer consumer demand outside of key selling periods.”
For the full year, Foot Locker now forecasts sales to dip between 1% and 1.5%, compared to previous guidance of down 1% to up 1%.
Foot Locker shares plunged 14% in premarket trading. As of Tuesday’s close, they were down 22% on the year.
Goldman’s Kate McShane has a “Sell” rating on Foot Locker with a “12-month price target of $25 based on our downside/base/upside case relative P/E multiples of 45%/50%/55.”
McShane noted some upside risks:
-
Event driven risk has increased: Given the change in vendor mix, the high cash balance, low debt levels, and recent decline in share price, FL could be a potential M&A or LBO candidate.
-
FL’s portfolio of brands remains strong: Despite the declining allocation of key Nike product, FL continues to have a portfolio of popular brands in its stores and online channels, including Nike, adidas, Reebok, Puma, and others. Moreover, FL has historically had higher levels of sneaker releases and innovation than other sneaker-selling retailers. These key strengths could support FL over the longer term.
-
New share repurchase authorization: FL’s board approved a significant $1.2bn share repurchase package. If FL repurchases shares at a faster rate than the market expects, it could drive upside to the stock.
Foot Locker’s customer base primarily consists of low-income consumers, offering a glimpse into discretionary spending trends. The dismal earnings and downshift in full-year outlook reveal that the bottom tier of consumers remains under significant financial strain due to elevated inflation, high interest rates, mounting credit card debt, and depleted personal savings. The ongoing inflation storm battering low-tier consumers results from an inflationary fallout from backfiring “Bidenomics.”
Tyler Durden Wed, 12/04/2024 – 08:35
Source: https://freedombunker.com/2024/12/04/foot-locker-plunges-on-softened-sneaker-demand/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.